1. Home
  2. PCT vs GLPG Comparison

PCT vs GLPG Comparison

Compare PCT & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

HOLD

Current Price

$10.57

Market Cap

1.8B

Sector

Utilities

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$33.62

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCT
GLPG
Founded
2015
1999
Country
United States
Belgium
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
PCT
GLPG
Price
$10.57
$33.62
Analyst Decision
Buy
Hold
Analyst Count
3
4
Target Price
$13.67
$31.33
AVG Volume (30 Days)
4.2M
105.9K
Earning Date
02-26-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,660,000.00
$336,643,201.00
Revenue This Year
N/A
$1.76
Revenue Next Year
$723.85
$0.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.31
52 Week Low
$5.40
$22.36
52 Week High
$17.37
$37.78

Technical Indicators

Market Signals
Indicator
PCT
GLPG
Relative Strength Index (RSI) 62.98 64.63
Support Level $9.88 $32.39
Resistance Level $10.75 $33.27
Average True Range (ATR) 0.51 0.67
MACD 0.22 0.05
Stochastic Oscillator 93.78 85.45

Price Performance

Historical Comparison
PCT
GLPG

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: